Concepedia

Kathleen M. Wood

KM

Statistics

Publications

20

Citations

957

H-Index

15

Active since

1980

Affiliations

Pfizer (United States)(Current)

Kathleen M. Wood is an author at Pfizer (United States) specializing in pharmacology, life sciences, and gamma secretase inhibition.

Publications per year

1980–2016

20

Publications

20

A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease

Justin R. Piro, Daniel I. Benjamin, James M. Duerr et al. · Cell Reports · 2012 · 227 citations · Full text

, , +17

Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.

Stuart A. Thompson, Shigeki Higashiyama, Kathleen M. Wood et al. · Journal of Biological Chemistry · 1994 · 152 citations · Full text

, , +15

Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139

Thomas A. Lanz, Michael J. Karmilowicz, Kathleen M. Wood et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 133 citations

, , +13

Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity

Kelly R. Bales, Sharon O'Neill, Nikolay Pozdnyakov et al. · Brain · 2015 · 67 citations · Full text

, , +17

Pharmacodynamics and Pharmacokinetics of the γ-Secretase Inhibitor PF-3084014

Thomas A. Lanz, Kathleen M. Wood, K. Richter et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 50 citations

, , +13

1–5 of 20